Transcripts
BioNTech (BNTX) earnings call transcripts
Earnings call transcripts for BioNTech SE, with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed 2026 as a transition toward a scaled, multi-product oncology company despite weaker COVID demand and delayed clinical milestones.
Aug 04, 2026Positive0.55